Back to search
Dapagliflozin Adverse Reaction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Dapagliflozin Adverse Reaction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Dapagliflozin Adverse Reaction trials you may qualify forBrief Summary Anthracyclines (e.g., doxorubicin) are effective anticancer agents but can cause dose-dependent, often irreversible cardiotoxicity via oxidative s…
The goal of this clinical trial is to examine the effectiveness of a drug named dapagliflozin (tested drug) on weight loss in young adults aged between 18 and 4…
The purpose of this study is to evaluate whether dapagliflozin reduces chemotherapy-induced cardiotoxicity in participants with breast cancer treated with (neo-…
The purpose of this study is to describe safety and efficacy of Dapaglifozin in adults patients with a systemic right ventricle (congenitally corrected transpos…